Deep Learning Models for Predicting Left Heart Abnormalities From Single-Lead Electrocardiogram for the Development of Wearable Devices.

Artificial intelligence Electrocardiography Single-lead ECG Wearable device

Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
14 Nov 2023
Historique:
medline: 16 11 2023
pubmed: 16 11 2023
entrez: 15 11 2023
Statut: aheadofprint

Résumé

Left heart abnormalities are risk factors for heart failure. However, echocardiography is not always available. Electrocardiograms (ECGs), which are now available from wearable devices, have the potential to detect these abnormalities. Nevertheless, whether a model can detect left heart abnormalities from single Lead I ECG data remains unclear.Methods and Results: We developed Lead I ECG models to detect low ejection fraction (EF), wall motion abnormality, left ventricular hypertrophy (LVH), left ventricular dilatation, and left atrial dilatation. We used a dataset comprising 229,439 paired sets of ECG and echocardiography data from 8 facilities, and validated the model using external verification with data from 2 facilities. The area under the receiver operating characteristic curves of our model was 0.913 for low EF, 0.832 for wall motion abnormality, 0.797 for LVH, 0.838 for left ventricular dilatation, and 0.802 for left atrial dilatation. In interpretation tests with 12 cardiologists, the accuracy of the model was 78.3% for low EF and 68.3% for LVH. Compared with cardiologists who read the 12-lead ECGs, the model's performance was superior for LVH and similar for low EF. From a multicenter study dataset, we developed models to predict left heart abnormalities using Lead I on the ECG. The Lead I ECG models show superior or equivalent performance to cardiologists using 12-lead ECGs.

Sections du résumé

BACKGROUND BACKGROUND
Left heart abnormalities are risk factors for heart failure. However, echocardiography is not always available. Electrocardiograms (ECGs), which are now available from wearable devices, have the potential to detect these abnormalities. Nevertheless, whether a model can detect left heart abnormalities from single Lead I ECG data remains unclear.Methods and Results: We developed Lead I ECG models to detect low ejection fraction (EF), wall motion abnormality, left ventricular hypertrophy (LVH), left ventricular dilatation, and left atrial dilatation. We used a dataset comprising 229,439 paired sets of ECG and echocardiography data from 8 facilities, and validated the model using external verification with data from 2 facilities. The area under the receiver operating characteristic curves of our model was 0.913 for low EF, 0.832 for wall motion abnormality, 0.797 for LVH, 0.838 for left ventricular dilatation, and 0.802 for left atrial dilatation. In interpretation tests with 12 cardiologists, the accuracy of the model was 78.3% for low EF and 68.3% for LVH. Compared with cardiologists who read the 12-lead ECGs, the model's performance was superior for LVH and similar for low EF.
CONCLUSIONS CONCLUSIONS
From a multicenter study dataset, we developed models to predict left heart abnormalities using Lead I on the ECG. The Lead I ECG models show superior or equivalent performance to cardiologists using 12-lead ECGs.

Identifiants

pubmed: 37967949
doi: 10.1253/circj.CJ-23-0216
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Masataka Sato (M)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Satoshi Kodera (S)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Naoto Setoguchi (N)

Division of Cardiology, Mitsui Memorial Hospital.

Kengo Tanabe (K)

Division of Cardiology, Mitsui Memorial Hospital.

Shunichi Kushida (S)

Department of Cardiovascular Medicine, Asahi General Hospital.

Junji Kanda (J)

Department of Cardiovascular Medicine, Asahi General Hospital.

Mike Saji (M)

Department of Cardiology, Sakakibara Heart Institute.

Mamoru Nanasato (M)

Department of Cardiology, Sakakibara Heart Institute.

Hisataka Maki (H)

Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University.

Hideo Fujita (H)

Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University.

Nahoko Kato (N)

Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center.

Hiroyuki Watanabe (H)

Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center.

Minami Suzuki (M)

Department of Cardiology, JR General Hospital.

Masao Takahashi (M)

Department of Cardiology, JR General Hospital.

Naoko Sawada (N)

Department of Cardiology, NTT Medical Center Tokyo.

Masao Yamasaki (M)

Department of Cardiology, NTT Medical Center Tokyo.

Shinnosuke Sawano (S)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Susumu Katsushika (S)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Hiroki Shinohara (H)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Norifumi Takeda (N)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Katsuhito Fujiu (K)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.
Department of Advanced Cardiology, The University of Tokyo.

Masao Daimon (M)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Hiroshi Akazawa (H)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Hiroyuki Morita (H)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Issei Komuro (I)

Department of Cardiovascular Medicine, The University of Tokyo Hospital.

Classifications MeSH